This information was published by Bupa's health information team and is based on reputable sources of medical evidence. It has been peer reviewed by Bupa doctors. The content is intended for general information only and does not replace the need for personal advice from a qualified health professional.
Parkinson's disease is a condition affecting the nervous system. It causes muscle tremor, stiffness and slowness of movement that becomes progressively worse over time. The condition was first described by Dr James Parkinson in 1817.
It affects approximately one in a hundred people over 65 year old, and one in ten people over 80. The symptoms of Parkinson's disease often begin around the age of 55.
The main symptoms of Parkinson's disease are:
- trembling (tremor) - though not always present, this is often the first sign of Parkinson's disease. It often starts in the arms and may spread to the face, jaw and legs
- stiffness (rigidity) – this makes the limbs feel weak and difficult to move. This may be intermittent or continuous. People with advanced Parkinson's disease may lose use of the limb altogether
- slowness – bradykinesia (slow movement) and akinesia (no movement) are common in people with Parkinson's disease. Walking may start with a hesitant step, followed by a shuffle without swinging the arms
As the disease progresses, other symptoms that develop include:
- problems with posture and balance – people with Parkinson's disease often stoop, fall forwards and lean to one side when sitting
- bowel and bladder problems – constipation is very common and there may be frequent urge to urinate
- speech changes – the voice becomes weak, and weakness of the swallowing muscles may cause drooling
- loss of facial expression – a mask-like appearance with loss of emotional expression gradually develops. Blinking and smiling are reduced
- small writing – commonly develops over time
- anxiety and depression – this occurs in about a third of people with Parkinson's disease
- intellect – slowness of thought and memory problems can develop in the later stages
There is no blood test for Parkinson's disease. Diagnosis is usually based on symptoms, and by ruling out other conditions that cause similar symptoms. This can often be done with an X-ray examination called computerised tomography (a CT scan), which is useful in detecting diseases that affect large areas of the brain. Then, if symptoms are reduced by treatments given for Parkinson's disease, its fairly certain that the person has Parkinson's disease.
Symptoms similar to Parkinson's disease can be a side-effect of some medications, such as anti-sickness drugs and drugs used in the treatment of mental illness. If this is the case, changing the medication should reduce symptoms.
In Parkinson's disease, production of a substance called dopamine in the brain is reduced. Dopamine is a neurotransmitter involved in passing messages within the brain and from the brain to the muscles. The part of the brain affected is called the substantia nigra, which co-ordinates muscle movement.
No one knows exactly what causes Parkinson's disease, but studies with identical twins suggest that genetic factors play a part. Also, some patients with generalised brain disease get Parkinson-like symptoms, which suggests that earlier damage to the brain might have a role in causing the disease. Parkinson's disease is not contagious.
Treatment with medication is aimed at restoring the levels of dopamine in the brain and controlling symptoms.
There are six main groups of drugs:
- drugs which replace dopamine – these are the most commonly used treatments. They are combinations of levodopa – a drug which breaks down in the body to form dopamine, plus a chemical which ensures the optimum dopamine concentration in the brain. They are effective at treating symptoms, although there are some side-effects. These include nausea, dizziness and constipation. Also, they can cause long term problems such as unwanted movements of the face and limbs (dyskinesia) and they may become less effective over time.
- drugs which mimic the action of dopamine – e.g. bromocriptine. Using these early on in the course of Parkinson's disease may delay the long-term problems of the dopamine replacement drugs. Side-effects can include nausea and hallucinations.
- drugs which block the action of acetylcholine – e.g. benzhexol. These help to correct the balance between dopamine and another chemical in the brain called acetylcholine. Side-effects can include dry mouth and blurred vision. They are not appropriate for people over 70 as they can cause memory loss, and urine retention in men.
- drugs which prevent the breakdown of dopamine – e.g. selegiline. This gives a little relief from symptoms and is also a mild antidepressant. Low blood pressure and irregular heartbeat are the most significant side effects.
- amantadine – acts like a dopamine replacement drug but works on different receptors. It can cause side-effects such as sedation at high doses.
- COMT (catechol O-methyl transferase) inhibitors – e.g. tolcapone. This is a new class of drugs that stops the breakdown of dopamine. They are usually given when dopamine replacement drugs start to lose their effectiveness. They can affect liver function, so blood tests are needed for the first few months.
This is currently used as a last resort when drugs no longer give benefits. Electrodes guided by X-rays (stereotactic surgery) are used to destroy the tiny areas of the brain responsible for tremor and abnormal movements.A device called a deep brain stimulator can also be used to give the same effect as stereotactic surgery, without destroying brain tissue. Radiosurgery is a new technique currently available at only a few specialised centres. It uses high energy radiation to focus on very precise areas of the brain. A new treatment, where brain tissue from human foetuses is transplanted into diseased areas of the brain, is at the experimental stage.
Other therapies that have an important role in managing and coping with Parkinson's disease include physiotherapy, speech therapy, and occupational therapy. Staying active will help to maintain normal muscle tone and function. A doctor or physiotherapist can recommend an appropriate range of exercises and activities.
1. Will doing exercise help to improve my symptoms?
Yes, doing suitable exercise can help to improve some of the symptoms of Parkinson's disease. It's also good for your general health and wellbeing.
One of the main symptoms of Parkinson's disease is stiffness and rigidity of your muscles and joints. Doing some form of exercise is important to keep your muscles supple, reduce stiffness and rigidity and reduce your risk of falls. Exercising can also improve your mood and help relieve depression, which can sometimes develop as a result of Parkinson's disease. Doing regular exercise will also help to improve your general health and fitness. This means that you may stay active for longer and therefore keep your independence for as long as possible.
People with Parkinson's disease can participate in many sports and activities, including swimming, walking and cycling. Group exercise sessions can be particularly good as they also offer you the chance to socialise. But it's important to only carry out exercise that is safe for you to do.
Ask your doctor for advice on what kind of exercise is suitable for you. He or she may refer you to a physiotherapist who will show you how to do some simple exercise routines that you can then do at home. A physiotherapist can also give you advice on how to move around your home more easily.
2. How quickly does Parkinson's disease progress?
The rate at which Parkinson's disease progresses varies from person to person.
Parkinson's disease is a progressive disease, meaning that your symptoms will gradually get worse over time. It's caused by a reduction in the number of cells that make a chemical transmitter in your brain called dopamine. This causes a reduction in the amount of dopamine in your brain. Once around 60 to 80 percent of the dopamine in your brain has been lost, you will begin to get the symptoms of Parkinson's disease.
The amount of dopamine in your brain will continue to fall very slowly, and as this happens the symptoms of the disease will get worse. Everyone is different, and the rate at which this happens will be individual to you.
3. Is there a cure for Parkinson's disease?
No, there is currently no cure for Parkinson's disease. However, there are medicines that can help to treat the symptoms of the disease.
Several types of medicine can be used to control the symptoms of Parkinson's disease. They do this by increasing the amount of dopamine in your brain, stimulating the areas of the brain where dopamine works or blocking the action of other chemicals that reduce the effectiveness of dopamine. Your doctor will prescribe medication that is suitable to control your symptoms.
Lots of research is being done to find more effective treatments for Parkinson's disease, including gene therapy and stem cell therapy.
Gene therapy is a technique in which normal genes are delivered directly to the parts of your brain that are affected by Parkinson's disease. This could help to protect your brain cells from the damage caused by Parkinson's disease and help the cells produce more dopamine.
Stem cells are special cells that may help to repair the cells in your brain. It's hoped that in the future it will be possible to use stem cells to replace the cells in your brain which have been lost because of Parkinson's disease. The stem cells would be healthy and able to produce dopamine.
These therapies are still at a very experimental stage and may not be available for some time. They offer some hope to better control the symptoms of Parkinson's disease or even cure the disease in the future.
This information was published by Bupa Group's Health Content Team and has been reviewed by appropriate medical or clinical professionals. To the best of their knowledge the information is current and based on reputable sources of medical evidence, however Bupa (Asia) Limited makes no representation or warranty as to the completeness or accuracy of the Content.
The information on this page, and any information on third party websites referred to on this page, is provided as a guide only. It should not be relied upon as a substitute for professional medical advice, nor is it intended to be used for medical diagnosis or treatment. Bupa (Asia) Limited is not liable for any loss or damage you suffer arising out of the use of, or reliance on, the information.
Third party websites are not owned or controlled by Bupa and any individual may be able to access and post messages on them. Bupa is not responsible for the content or availability of these third party websites. Last updated August 2017.
- HK Parkinsons Disease Association
TEL : 27943010 / 23372292 / 9183 3869
- The Parkinsons Disease Society
Helpline (freephone): 0808 800 0303
- Awakenings – The Internet focus on Parkinson’s disease
- National Parkinson Foundation
- National Institute of Neurological Disorders and Stroke (NINDS)
- Brain and Spine Foundation
0808 808 1000
- Parkinson's disease. Clinical Knowledge Summaries.www.cks.nhs.uk, accessed 5 November 2010
- Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009; 373(9680):2055–66
- About Parkinson's. Parkinson's UK.www.parkinsons.org.uk, accessed 5 November 2010
- Parkinson's disease. eMedicine.www.emedicine.medscape.com, accessed 5 November 2010
- Hamza TH, Zabetian CP, Tenesa A et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genetics 2010; 42:781–85
- Diagnosis and pharmacological management of Parkinson's disease: a national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN), 2010, 113.www.sign.ac.uk
- Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. National Institute for Health and Clinical Excellence (NICE), 2006.www.nice.org.uk
- Diagnosis and scans. Parkinson's UK, 2008.www.parkinsons.org.uk
- Joint Formulary Committee. British National Formulary. 60th ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2010
- Deep brain stimulation for Parkinson's disease. National Institute for Health and Clinical Excellence (NICE), 2003.www.nice.org.uk
- Depression and Parkinson's. Parkinson's UK, 2009.www.parkinsons.org.uk
- Keeping moving: exercise and Parkinson's. Parkinson's UK, 2009.www.parkinsons.org.uk
Talk to us
Contact our health management consultant to get details and advice.2517 5860
Mon-Fri 9am-9pm, Sat 9am-1pm (except public holidays)